Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Active not recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 27Stomach Neoplasms 11Rectal Neoplasms 10Pancreatic Neoplasms 10Colonic Neoplasms 10Esophageal Neoplasms 9Adenocarcinoma Of Esophagus 8Neoplasm Metastasis 7Urinary Bladder Neoplasms 6Carcinoma, Non-Small-Cell Lung 6Neoplasms 5Cholangiocarcinoma 5Adenocarcinoma 5Squamous Cell Carcinoma of Head and Neck 4Parkinson Disease 4, Autosomal Dominant Lewy Body 4Ovarian Neoplasms 3Gastrointestinal Neoplasms 3Esophageal Squamous Cell Carcinoma 3Endometrial Neoplasms 3Carcinoma, Hepatocellular 3Uterine Cervical Neoplasms 2Triple Negative Breast Neoplasms 2Melanoma 2Lung Neoplasms 2Gallbladder Neoplasms 2Carcinoma 2Biliary Tract Neoplasms 2Urothelial Carcinoma of the Bladder 1Urologic Neoplasms 1Urologic Diseases 1

Interventions

pembrolizumab 1Fluorouracil 1Cisplatin 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Fluorouracil × 30 days × Clear all
NCT06057038 2026-06-02

A Safety Trial of GEN1042 in Japanese Subjects With Malignant Solid Tumors

Genmab

Phase 1 Active not recruiting
42 enrolled
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡